JP2023547396A5 - - Google Patents
Info
- Publication number
- JP2023547396A5 JP2023547396A5 JP2023524715A JP2023524715A JP2023547396A5 JP 2023547396 A5 JP2023547396 A5 JP 2023547396A5 JP 2023524715 A JP2023524715 A JP 2023524715A JP 2023524715 A JP2023524715 A JP 2023524715A JP 2023547396 A5 JP2023547396 A5 JP 2023547396A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- pharmaceutically acceptable
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105013P | 2020-10-23 | 2020-10-23 | |
| US63/105,013 | 2020-10-23 | ||
| PCT/US2021/056127 WO2022087326A1 (en) | 2020-10-23 | 2021-10-22 | Heterocyclic compounds and their use for treatment of helminthic infections and diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547396A JP2023547396A (ja) | 2023-11-10 |
| JP2023547396A5 true JP2023547396A5 (https=) | 2024-10-29 |
Family
ID=78676658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524715A Pending JP2023547396A (ja) | 2020-10-23 | 2021-10-22 | 蠕虫感染及び疾患の処置のための複素環式化合物及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240025891A1 (https=) |
| EP (1) | EP4232449A1 (https=) |
| JP (1) | JP2023547396A (https=) |
| KR (1) | KR20230092972A (https=) |
| CN (1) | CN116547282A (https=) |
| WO (1) | WO2022087326A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021311722A1 (en) | 2020-07-24 | 2023-02-02 | Elanco Us Inc. | Process for making an isoxazoline compound and intermediate thereof |
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| BR112023024571A2 (pt) | 2021-05-27 | 2024-02-06 | Boundless Bio Inc | Inibidores de quinase do ponto de verificação 1 (chk1) e usos dos mesmos |
| CN119546588A (zh) * | 2022-05-24 | 2025-02-28 | 无界生物公司 | 吡啶检查点激酶1（chk1）抑制剂及其用途 |
| JP2025540059A (ja) * | 2022-11-29 | 2025-12-11 | バウンドレス バイオ，インク． | チェックポイントキナーゼ１（ｃｈｋ１）阻害剤の組合せおよびその使用 |
| CN115819429A (zh) * | 2022-12-13 | 2023-03-21 | 成都睿智化学研究有限公司 | 一种5-氯-2,3-二氢呋喃[2,3-c]吡啶的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995005368A1 (en) * | 1993-08-13 | 1995-02-23 | Zeneca Limited | Thia- and oxadiazole derivatives and their use as fungicides or insecticides |
| US5614470A (en) * | 1994-04-01 | 1997-03-25 | Sankyo Company, Limited | 13-substituted milbemycin derivatives, their preparation and their use |
| AU2005232753A1 (en) * | 2004-04-13 | 2005-10-27 | Astellas Pharma Inc. | Polycylic thiazoles as potassium ion channel modulators |
| SG11201401207XA (en) * | 2011-10-04 | 2014-05-29 | Inst Hepatitis & Virus Res | Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication |
| WO2014210319A2 (en) * | 2013-06-26 | 2014-12-31 | The Trustees Of Columbia University In The City Of New York | Inhibitors of plasmodium falciparum equilibrative nucleoside transporter type 1 as anti-parasitic compounds |
| BR112017019326B1 (pt) * | 2015-03-12 | 2022-04-26 | Fmc Corporation | Composto, composição e método para controlar uma praga invertebrada |
| EP3481810A4 (en) * | 2016-07-11 | 2019-05-29 | Baruch S. Blumberg Institute | SUBSTITUTED AMINOTHIAZOLE |
| CN114072395A (zh) * | 2019-04-26 | 2022-02-18 | 新基公司 | 杂环化合物及其治疗蠕虫感染和疾病的用途 |
-
2021
- 2021-10-22 KR KR1020237016754A patent/KR20230092972A/ko active Pending
- 2021-10-22 EP EP21810484.2A patent/EP4232449A1/en active Pending
- 2021-10-22 CN CN202180071227.3A patent/CN116547282A/zh active Pending
- 2021-10-22 JP JP2023524715A patent/JP2023547396A/ja active Pending
- 2021-10-22 WO PCT/US2021/056127 patent/WO2022087326A1/en not_active Ceased
- 2021-10-22 US US18/032,998 patent/US20240025891A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023547396A5 (https=) | ||
| DE60217674T2 (de) | Derivate heterocyclischer verbindungen und arzneimittel | |
| RU2435757C2 (ru) | Производные 3-циклил-2-(4-сульфамоилфенил)-n-циклилпропионамида, применимые для лечения нарушенной переносимости глюкозы и диабета | |
| JP5524853B2 (ja) | 肺疾患及び心臓血管疾患を治療するための置換されたベンゾアゾールｐｄｅ４阻害剤 | |
| RU2003105805A (ru) | Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1 | |
| JP2019512505A5 (https=) | ||
| JP2008513508A5 (https=) | ||
| JP2015533782A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2009529047A5 (https=) | ||
| US8637527B2 (en) | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 | |
| JP2021514373A5 (https=) | ||
| JP2016509583A5 (https=) | ||
| RU2003102612A (ru) | N-окиси в качестве пролекарств производных 4-фенилпиридина, являющихся натагонистами рецептора nk-1 | |
| RU2012117398A (ru) | Бензоксазепиновые ингибиторы pi3 и способы применения | |
| RU2007105685A (ru) | Производные гидантонина для лечения воспалительных заболеваний | |
| RU2002134487A (ru) | Бензофены как ингибиторы il-1бета и tnf-альфа | |
| JP2022501429A5 (https=) | ||
| TWI904076B (zh) | 作為用於治療神經退化性疾病的ppargc1a活化劑的2-芳基苯并咪唑 | |
| WO2003084544A2 (en) | Compounds dor increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis | |
| JP2009530396A (ja) | Ｔｒｐｖ１のモジュレーターとしてのテトラヒドロ−ピリミドアゼピン | |
| JP2022546414A5 (https=) | ||
| JP2020511452A5 (https=) | ||
| CA2679198A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| RU2007120692A (ru) | Новые антраниламидопиридинмочевины в качестве ингибитов киназы рецептора vegf | |
| JP2023513419A (ja) | オーロラａ選択的阻害剤として有用な新規複素環式化合物 |